Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Charles Fruchart

Showing results (31-40 of 167) with videos related to

Pageof 17
Sort By:
Atherosclerosis|July 18, 2002
Apolipoprotein A-II, HDL metabolism and atherosclerosisAnne Tailleux, Patrick Duriez, Jean-Charles Fruchart, et al.
The New England Journal of Medicine|September 16, 2010
Combination lipid therapy in type 2 diabetesFrank M Sacks, Vincent J Carey, Jean-Charles Fruchart
Diabetes & Metabolic Syndrome|August 14, 2019
Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?Jean-Charles Fruchart, Raul D Santos, Shizuya Yamashita, et al.
Biochimica Et Biophysica Acta|March 14, 2003
Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosisLesley J Millatt, Virginie Bocher, Jean Charles Fruchart, et al.
Current Opinion in Lipidology|March 19, 2003
Liver X receptors: new players in atherogenesis?Virginie Bocher, Lesley J Millatt, Jean-Charles Fruchart, et al.
Annals of the New York Academy of Sciences|June 25, 2002
PPARs: transcription factors controlling lipid and lipoprotein metabolismVirginie Bocher, Ines Pineda-Torra, Jean-Charles Fruchart, et al.
Biochimie|March 1, 2005
Potential regulatory role of the farnesoid X receptor in the metabolic syndromeDaniel Duran-Sandoval, Bertrand Cariou, Jean-Charles Fruchart, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 29, 2003
Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammationChristophe Blanquart, Olivier Barbier, Jean Charles Fruchart, et al.
Trends in Molecular Medicine|September 12, 2002
The role of PPARs in atherosclerosisCaroline Duval, Giulia Chinetti, Francois Trottein, et al.
Current Atherosclerosis Reports|January 4, 2021
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib, et al.
Pageof 17

Showing results (31-40 of 167) with videos related to

Sort By:
Pageof 17
Atherosclerosis|July 18, 2002
Apolipoprotein A-II, HDL metabolism and atherosclerosisAnne Tailleux, Patrick Duriez, Jean-Charles Fruchart, et al.
The New England Journal of Medicine|September 16, 2010
Combination lipid therapy in type 2 diabetesFrank M Sacks, Vincent J Carey, Jean-Charles Fruchart
Diabetes & Metabolic Syndrome|August 14, 2019
Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?Jean-Charles Fruchart, Raul D Santos, Shizuya Yamashita, et al.
Biochimica Et Biophysica Acta|March 14, 2003
Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosisLesley J Millatt, Virginie Bocher, Jean Charles Fruchart, et al.
Current Opinion in Lipidology|March 19, 2003
Liver X receptors: new players in atherogenesis?Virginie Bocher, Lesley J Millatt, Jean-Charles Fruchart, et al.
Annals of the New York Academy of Sciences|June 25, 2002
PPARs: transcription factors controlling lipid and lipoprotein metabolismVirginie Bocher, Ines Pineda-Torra, Jean-Charles Fruchart, et al.
Biochimie|March 1, 2005
Potential regulatory role of the farnesoid X receptor in the metabolic syndromeDaniel Duran-Sandoval, Bertrand Cariou, Jean-Charles Fruchart, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 29, 2003
Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammationChristophe Blanquart, Olivier Barbier, Jean Charles Fruchart, et al.
Trends in Molecular Medicine|September 12, 2002
The role of PPARs in atherosclerosisCaroline Duval, Giulia Chinetti, Francois Trottein, et al.
Current Atherosclerosis Reports|January 4, 2021
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib, et al.
Pageof 17